This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Jung-Whoi Lee in Cholangiocarcinoma Treatment
Introduction
Jung-Whoi Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the treatment of cholangiocarcinoma, a type of cancer that affects the bile ducts. His innovative work has led to the development of a pharmaceutical composition aimed at inhibiting the growth and invasion of cholangiocarcinoma cells.
Latest Patents
Jung-Whoi Lee holds a patent for a pharmaceutical composition for treating cholangiocarcinoma. This patent includes a method for inhibiting the growth or invasion of cholangiocarcinoma, which is crucial for improving patient outcomes. The composition comprises an L1CAM activity inhibitor or expression suppressor. The findings indicate that L1CAM is overexpressed in cholangiocarcinoma and plays a vital role in the disease's progression. The patent outlines the use of antibodies that inhibit L1CAM activity or siRNAs that suppress its expression, both of which have shown promise in reducing the growth and invasion of cholangiocarcinoma cells.
Career Highlights
Jung-Whoi Lee is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work has been instrumental in advancing the understanding of cholangiocarcinoma and developing targeted therapies. His research has the potential to significantly impact the treatment landscape for patients suffering from this aggressive cancer.
Collaborations
Jung-Whoi Lee has collaborated with notable colleagues, including Hyo Jeong Hong and Jin Man Kim. Their combined expertise has contributed to the successful development of innovative treatment methods for cholangiocarcinoma.
Conclusion
Jung-Whoi Lee's contributions to the field of biotechnology, particularly in the treatment of cholangiocarcinoma, highlight the importance of innovation in medical research. His patented methods and compositions offer hope for improved treatment options for patients facing this challenging disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile